Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of metabolic complications of glucocorticoid excess with metformin
2008-005708-18Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), polymyalgia rheumatica (PMR) and 3 more, sponsored by Queen Mary University of London. Primary endpoint: Change in visceral to subcutaneous fat area ratio. Started Apr 2010; status: completed.
02
Drugs
metformin
03
Conditions
rheumatoid arthritis (RA)systemic lupus erythematosus (SLE)polymyalgia rheumatica (PMR)Graves Orbitopathy (GO)Cushing's syndrome
Beyond the preview
Go deeper on 2008-005708-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005708-18.